The Road to 2021
Road to 2021 Day 24: France
Nigel Walker
Nice Insight
PAO-04-22-R221-51Jan 01, 2021
Servier Acquires Symphogen
Servier
PR-M04-20-NI-006Apr 03, 2020
Serialization Update
Revisiting the Global Serialization Landscape
Michael Kinsella
Servier
PAP-Q2-2019-CL-030May 24, 2019
Expansion
Servier Cuts Ribbon on New Boston Headquarters
Servier
PR-M05-19-NI-037May 13, 2019
DCAT '19
Highly Potent API and Sterile Capabilities Key to DCAT Week ‘19 Company Announcements
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M03-19-NI-024Mar 18, 2019
Collaboration
Amgen, Cytokinetics and Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure
Amgen
PR-M02-19-NI-052Feb 22, 2019
Global Network
Risk Minimization with an Integrated Global Network
Servier
PAP-Q4-18-CL-005Oct 26, 2018
Design Logic
Preparative Chromatography
Nice Insight
PAP-Q4-18-NI-002Oct 26, 2018
Chromatography
Accelerating Time to Market with Integrated Preparative Chromatography Support
Christophe Berini
Servier
PAP-Q3-18-CL-010Oct 02, 2018
Announcement
Shire Exec Selected to Run Servier Pharmaceuticals U.S.
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M07-18-NI-015Jul 24, 2018
Regulatory
Reducing Time to Market with Targeted Regulatory Affairs Support
Maryse Phan
Servier
PAO-06-18-CL-003Jun 20, 2018
Corporate Social Responsibility
Corporate Social Responsibility as a Driver for Improved Sustainability
Allain de Wilde; Loïc Allanos
Servier
PAP-Q2-18-CL-014May 29, 2018
Endpoint
Phase III Study Evaluating the Efficacy and Safety of Lonsurf in Patients with Metastatic Gastric Cancer Meets Primary Endpoint
Servier
PR-M05-18-NI-040May 10, 2018
Acquisition
Shire Announces Sale of Oncology Business to Servier for $2.4 Billion
Servier
PR-M04-18-NI-59Apr 16, 2018
Operational Excellence
Transforming A CDMO Using an Operational Excellence Approach
Sébastien Mathieu; Laurent Dray
Servier
PAO-M03-18-CL-003Mar 29, 2018
Innovation
WeHealth by Servier and DEEPLINK MEDICAL sign a partnership to develop a new e-health solution
Servier
PR-M03-18-NI-059Mar 16, 2018
Industry
Why Business Continuity Management is Important for CDMOs
Mayeul Cauvin
Servier
PAP-Q1-18-CL-003Mar 12, 2018
Servier Reports Year-On-Year Growth
Guy Tiene
Nice Insight
PAO-M02-18-NI-024Feb 27, 2018
Strategic Partnership
ImmunoQure AG and Servier Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody
Servier
PR-M02-18-NI-64-4706Feb 14, 2018
Symposium
Taiho Oncology and Servier Present LONSURF® (trifluridine and tipiracil) Metastatic Colorectal Cancer (mCRC) Data at ASCO 2018 Gastrointestinal Cancers Symposium
Taiho Oncology, Inc.
PR-M01-18-NI-080Jan 25, 2018